Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TCF4 | P15884 | 1/20 | 0.70 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.70 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.70 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.59 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 6/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.57 |
| ▸ | MAPT | P10636 | 6/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 4/20 | 0.56 |
| ▸ | RAB9A | P51151 | 4/20 | 0.56 |
| ▸ | POLB | P06746 | 3/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.53 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.53 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.53 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.53 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12009051 | 1.00 | TCF4 (0.70) | TCF4CTNNB1HDAC6NR1H4MDM2 | |
| SCHEMBL12009024 | 0.95 | NR1H4 (0.64) | TCF4CTNNB1HDAC6NR1H4MDM2 | |
| SCHEMBL12009114 | 0.93 | TCF4 (0.79) | TCF4CTNNB1HDAC6NR1H4MDM2 | |
| SCHEMBL12006922 | 0.93 | TCF4 (0.79) | TCF4CTNNB1HDAC6NR1H4MDM2 | |
| SCHEMBL18545525 | 0.93 | TCF4 (0.79) | TCF4CTNNB1HDAC6NR1H4MDM2 | |
| SCHEMBL12009025 | 0.92 | NR1H4 (0.60) | TCF4CTNNB1HDAC6NR1H4MDM2 | |
| SCHEMBL18545653 | 0.92 | NR1H4 (0.60) | TCF4CTNNB1HDAC6NR1H4MDM2 | |
| SCHEMBL12009059 | 0.91 | TCF4 (0.70) | TCF4CTNNB1HDAC6NR1H4MDM2 | |
| SCHEMBL18545530 | 0.91 | TCF4 (0.70) | TCF4CTNNB1HDAC6NR1H4MDM2 | |
| SCHEMBL18545612 | 0.91 | TCF4 (0.73) | TCF4CTNNB1HDAC6NR1H4MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170049751-A1 | OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF | DASGUPTA RAMANUJ (US) | 2017-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170049751-A1 | OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF | CTNNB1, CTNNA1, CTNNBL1 | TCF4 24/4885CTNNB1 1/4885HDAC6 74/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.